A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations

Neonatology. 2017;112(4):387-393. doi: 10.1159/000478651. Epub 2017 Sep 20.

Abstract

Background: Recurrent and prolonged seizures are harmful for the developing brain, emphasizing the importance of early seizure recognition and effective therapy. Amplitude-integrated electroencephalography (aEEG) has become a valuable tool to diagnose epileptic seizures, and, in parallel, genetic etiologies are increasingly being recognized, changing the paradigm of the workup and management of neonatal seizures.

Objective: To report the ictal aEEG pattern in neonates with KCNQ2-related epilepsy.

Subjects and methods: In this multicenter descriptive study, clinical data and aEEG findings of 9 newborns with KCNQ2 mutations are reported.

Results: Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation. A distinct aEEG seizure pattern, consisting of a sudden rise of the lower and upper margin of the aEEG, followed by a marked depression of the aEEG amplitude, was found in 8 of the 9 patients. Prompt recognition of this pattern led to early treatment with carbamazepine in the 2 most recent cases.

Conclusion: Early recognition of the electroclinical phenotype by using aEEG may direct genetic testing and a precision medicine approach with sodium channel blockers in neonates with KCNQ2 mutations.

Keywords: Amplitude-integrated electroencephalography; Carbamazepine; KCNQ2 mutations; KCNQ2-related epilepsy; Neonatal seizures.

Publication types

  • Multicenter Study

MeSH terms

  • Anticonvulsants / therapeutic use
  • Brain / drug effects
  • Brain / physiopathology*
  • Brain Waves* / drug effects
  • Carbamazepine / therapeutic use
  • DNA Mutational Analysis
  • Electroencephalography*
  • Genetic Predisposition to Disease
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases / diagnosis
  • Infant, Newborn, Diseases / drug therapy
  • Infant, Newborn, Diseases / genetics*
  • Infant, Newborn, Diseases / physiopathology
  • KCNQ2 Potassium Channel / genetics*
  • Mutation*
  • Netherlands
  • Phenotype
  • Portugal
  • Predictive Value of Tests
  • Seizures / diagnosis
  • Seizures / drug therapy
  • Seizures / genetics*
  • Seizures / physiopathology
  • Treatment Outcome

Substances

  • Anticonvulsants
  • KCNQ2 Potassium Channel
  • KCNQ2 protein, human
  • Carbamazepine